News Ipsen's Cabometyx recommended by NICE for previously treated... French drugmaker Ipsen’s Cabometyx (cabozantinib) has been recommended by the National Institute for Health and Care
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
